Nutraceutix Awarded Probiotic Delivery Patent in China

REDMOND, Wash. Nutraceutix Inc. announced it received notice from the Chinese Patent Office on a new patent (No. 02823678.5) covering the companys BIO-tract delivery system; this is the fourth international patent Nutraceutix holds on the technology, used to deliver sensitive ingredients such as probiotics to optimal delivery sites in the intestinal tract. The BIO-tract tablets form a protective layer when ingested, shielding the contents from the acidic conditions of the stomach and releasing the active compounds at optimal rates and locations in the intestinal tract, based on formulation.

Steve Moger, president and CEO, commented: Years ago, we recognized the need for an effective probiotic and nutraceutical delivery technologyone that draws upon proven pharmaceutical principles, yet is economically feasible in the nutritional supplement marketplace. Our research and development investments in BIO-tract continue to be validated by yet another key patent.